The global strep throat treatment market size is calculated at USD 2.29 billion in 2025 and is forecasted to reach around USD 3.37 billion by 2034, accelerating at a CAGR of 4.40% from 2025 to 2034. The North America strep throat treatment market size surpassed USD 850 million in 2024 and is expanding at a CAGR of 4.50% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Strep Throat Treatment Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Strep Throat Treatment Market, by Disease Type
8.1.1. Acute Strep Throat
8.1.1.1. Market Revenue and Forecast
8.1.2. Pharyngitis
8.1.2.1. Market Revenue and Forecast
8.1.3. Tonsillitis
8.1.3.1. Market Revenue and Forecast
8.1.4. Laryngitis
8.1.4.1. Market Revenue and Forecast
9.1. Strep Throat Treatment Market, by Treatment Type
9.1.1. Antibiotics
9.1.1.1. Market Revenue and Forecast
9.1.2. Pain Relievers
9.1.2.1. Market Revenue and Forecast
10.1. Strep Throat Treatment Market, by Diagnosis
10.1.1. Antibody Test
10.1.1.1. Market Revenue and Forecast
10.1.2. Physical Examination
10.1.2.1. Market Revenue and Forecast
10.1.3. Throat Culture
10.1.3.1. Market Revenue and Forecast
11.1. Strep Throat Treatment Market, by Route Of Administration
11.1.1. Oral
11.1.1.1. Market Revenue and Forecast
11.1.2. Topical
11.1.2.1. Market Revenue and Forecast
11.1.3. Injectable
11.1.3.1. Market Revenue and Forecast
12.1. Strep Throat Treatment Market, by End-use
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast
12.1.2. Specialty Clinics
12.1.2.1. Market Revenue and Forecast
12.1.3. Diagnostic Laboratories
12.1.3.1. Market Revenue and Forecast
13.1. Strep Throat Treatment Market, by Distribution Channel
13.1.1. Hospital Pharmacy
13.1.1.1. Market Revenue and Forecast
13.1.2. Retail Pharmacy
13.1.2.1. Market Revenue and Forecast
13.1.3. Online Pharmacy
13.1.3.1. Market Revenue and Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Disease Type
14.1.2. Market Revenue and Forecast, by Treatment Type
14.1.3. Market Revenue and Forecast, by Diagnosis
14.1.4. Market Revenue and Forecast, by Route Of Administration
14.1.5. Market Revenue and Forecast, by End-use
14.1.6. Market Revenue and Forecast, by Distribution Channel
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Disease Type
14.1.7.2. Market Revenue and Forecast, by Treatment Type
14.1.7.3. Market Revenue and Forecast, by Diagnosis
14.1.7.4. Market Revenue and Forecast, by Route Of Administration
14.1.8. Market Revenue and Forecast, by End-use
14.1.8.1. Market Revenue and Forecast, by Distribution Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Disease Type
14.1.9.2. Market Revenue and Forecast, by Treatment Type
14.1.9.3. Market Revenue and Forecast, by Diagnosis
14.1.9.4. Market Revenue and Forecast, by Route Of Administration
14.1.10. Market Revenue and Forecast, by End-use
14.1.11. Market Revenue and Forecast, by Distribution Channel
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Disease Type
14.2.2. Market Revenue and Forecast, by Treatment Type
14.2.3. Market Revenue and Forecast, by Diagnosis
14.2.4. Market Revenue and Forecast, by Route Of Administration
14.2.5. Market Revenue and Forecast, by End-use
14.2.6. Market Revenue and Forecast, by Distribution Channel
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Disease Type
14.2.8.2. Market Revenue and Forecast, by Treatment Type
14.2.8.3. Market Revenue and Forecast, by Diagnosis
14.2.9. Market Revenue and Forecast, by Route Of Administration
14.2.10. Market Revenue and Forecast, by End-use
14.2.10.1. Market Revenue and Forecast, by Distribution Channel
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Disease Type
14.2.11.2. Market Revenue and Forecast, by Treatment Type
14.2.11.3. Market Revenue and Forecast, by Diagnosis
14.2.12. Market Revenue and Forecast, by Route Of Administration
14.2.13. Market Revenue and Forecast, by End-use
14.2.14. Market Revenue and Forecast, by Distribution Channel
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Disease Type
14.2.15.2. Market Revenue and Forecast, by Treatment Type
14.2.15.3. Market Revenue and Forecast, by Diagnosis
14.2.15.4. Market Revenue and Forecast, by Route Of Administration
14.2.16. Market Revenue and Forecast, by End-use
14.2.16.1. Market Revenue and Forecast, by Distribution Channel
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Disease Type
14.2.17.2. Market Revenue and Forecast, by Treatment Type
14.2.17.3. Market Revenue and Forecast, by Diagnosis
14.2.17.4. Market Revenue and Forecast, by Route Of Administration
14.2.18. Market Revenue and Forecast, by End-use
14.2.18.1. Market Revenue and Forecast, by Distribution Channel
14.3. APAC
14.3.1. Market Revenue and Forecast, by Disease Type
14.3.2. Market Revenue and Forecast, by Treatment Type
14.3.3. Market Revenue and Forecast, by Diagnosis
14.3.4. Market Revenue and Forecast, by Route Of Administration
14.3.5. Market Revenue and Forecast, by End-use
14.3.6. Market Revenue and Forecast, by Distribution Channel
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Disease Type
14.3.7.2. Market Revenue and Forecast, by Treatment Type
14.3.7.3. Market Revenue and Forecast, by Diagnosis
14.3.7.4. Market Revenue and Forecast, by Route Of Administration
14.3.8. Market Revenue and Forecast, by End-use
14.3.9. Market Revenue and Forecast, by Distribution Channel
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Disease Type
14.3.10.2. Market Revenue and Forecast, by Treatment Type
14.3.10.3. Market Revenue and Forecast, by Diagnosis
14.3.10.4. Market Revenue and Forecast, by Route Of Administration
14.3.11. Market Revenue and Forecast, by End-use
14.3.11.1. Market Revenue and Forecast, by Distribution Channel
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Disease Type
14.3.12.2. Market Revenue and Forecast, by Treatment Type
14.3.12.3. Market Revenue and Forecast, by Diagnosis
14.3.12.4. Market Revenue and Forecast, by Route Of Administration
14.3.12.5. Market Revenue and Forecast, by End-use
14.3.12.6. Market Revenue and Forecast, by Distribution Channel
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Disease Type
14.3.13.2. Market Revenue and Forecast, by Treatment Type
14.3.13.3. Market Revenue and Forecast, by Diagnosis
14.3.13.4. Market Revenue and Forecast, by Route Of Administration
14.3.13.5. Market Revenue and Forecast, by End-use
14.3.13.6. Market Revenue and Forecast, by Distribution Channel
14.4. MEA
14.4.1. Market Revenue and Forecast, by Disease Type
14.4.2. Market Revenue and Forecast, by Treatment Type
14.4.3. Market Revenue and Forecast, by Diagnosis
14.4.4. Market Revenue and Forecast, by Route Of Administration
14.4.5. Market Revenue and Forecast, by End-use
14.4.6. Market Revenue and Forecast, by Distribution Channel
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Disease Type
14.4.7.2. Market Revenue and Forecast, by Treatment Type
14.4.7.3. Market Revenue and Forecast, by Diagnosis
14.4.7.4. Market Revenue and Forecast, by Route Of Administration
14.4.8. Market Revenue and Forecast, by End-use
14.4.9. Market Revenue and Forecast, by Distribution Channel
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Disease Type
14.4.10.2. Market Revenue and Forecast, by Treatment Type
14.4.10.3. Market Revenue and Forecast, by Diagnosis
14.4.10.4. Market Revenue and Forecast, by Route Of Administration
14.4.11. Market Revenue and Forecast, by End-use
14.4.12. Market Revenue and Forecast, by Distribution Channel
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Disease Type
14.4.13.2. Market Revenue and Forecast, by Treatment Type
14.4.13.3. Market Revenue and Forecast, by Diagnosis
14.4.13.4. Market Revenue and Forecast, by Route Of Administration
14.4.13.5. Market Revenue and Forecast, by End-use
14.4.13.6. Market Revenue and Forecast, by Distribution Channel
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Disease Type
14.4.14.2. Market Revenue and Forecast, by Treatment Type
14.4.14.3. Market Revenue and Forecast, by Diagnosis
14.4.14.4. Market Revenue and Forecast, by Route Of Administration
14.4.14.5. Market Revenue and Forecast, by End-use
14.4.14.6. Market Revenue and Forecast, by Distribution Channel
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Disease Type
14.5.2. Market Revenue and Forecast, by Treatment Type
14.5.3. Market Revenue and Forecast, by Diagnosis
14.5.4. Market Revenue and Forecast, by Route Of Administration
14.5.5. Market Revenue and Forecast, by End-use
14.5.6. Market Revenue and Forecast, by Distribution Channel
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Disease Type
14.5.7.2. Market Revenue and Forecast, by Treatment Type
14.5.7.3. Market Revenue and Forecast, by Diagnosis
14.5.7.4. Market Revenue and Forecast, by Route Of Administration
14.5.8. Market Revenue and Forecast, by End-use
14.5.8.1. Market Revenue and Forecast, by Distribution Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Disease Type
14.5.9.2. Market Revenue and Forecast, by Treatment Type
14.5.9.3. Market Revenue and Forecast, by Diagnosis
14.5.9.4. Market Revenue and Forecast, by Route Of Administration
14.5.9.5. Market Revenue and Forecast, by End-use
14.5.9.6. Market Revenue and Forecast, by Distribution Channel
15.1. Pfizer Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. AstraZeneca
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Novartis AG
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Bayer AG
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. GSK Plc.
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Amgen Inc.
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Merck & Co, Inc.
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Sanofi
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Mitsubishi Chemical Group Corp.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Teva Pharmaceutical Industries Ltd.
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample